F/M Emr Life Sciences in ETFLFSCETF
13F holders, Q4 2025 (December 31)7holders +4
5new positions
1sold out
$36.62avg. 13F price*
At the end of Q4 2025, 7 institutions reported holding F/M Emr Life Sciences in ETF (LFSC) in their 13F filings, up 4 from Q3 2025. 5 opened new positions and 1 sold out. The largest holders were Emerald Mutual Fund Advisers Trust ($73.1M), Susquehanna International Group, LLP ($9.3M) and Hunter Associates Investment Management LLC ($1.7M).
- Company
- F/M Emr Life Sciences in ETF
- Filed as
- RBB FD INC (Q4 2025)
- CUSIP
- 74933W221
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $10.9M |
| Exits | 1 | $3K |
All 13F filers, Q3 2025 → Q4 2025: 301,668 shares bought and 100 shares sold, net +301,568 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Emerald Mutual Fund Advisers Trust | 3.56% | No change | 1,997,035 | $73.1M |
| Susquehanna International Group, LLP | 0.01% | New | 253,148 | $9.3M |
| Hunter Associates Investment Management LLC | 0.23% | Add +13.1% | 45,908 | $1.7M |
| Tidal Investments LLC | 0.00% | New | 17,004 | $623K |
| MML Investors Services, LLC | 0.00% | New | 13,592 | $498K |
| Envestnet Asset Management Inc. | 0.00% | New | 12,267 | $449K |
| UBS Group AG | 0.00% | New | 345 | $13K |
"% of holder's portfolio" is LFSC's weight in each manager's 13F, not the share of F/M Emr Life Sciences in ETF the manager owns.